Foreign investors have pulled out nearly Rs 8,000 crore from the Indian capital markets so far this month due to considerable volatility in global markets.
Foreign investors have pumped in Rs 3,935 cr into the Indian debt markets in the first fortnight of the month, driven by a stable currency and attractive bond yields.
Sebi came out with a detailed framework in order to identify and verify beneficial owners of foreign portfolio investors (FPIs).
BSE will auction investment limits for foreign investors to purchase government bonds worth over Rs 11,000 crore tomorrow.
Net inflow by foreign portfolio investors (FPIs) in equities stood at Rs 8,440 crore during March 1-23.
Foreign investors have pulled out nearly Rs 6,000 crore from the Indian capital markets due to better opportunities in other emerging nations.
Foreign investors have pulled out so far this month a staggering USD 1 billion or Rs 6,850 crore from the Indian stock market in the wake of sell-offs globally.
Sebi has eased the norms for foreign portfolio investors, doing away with the prior-approval requirement in case of change in local custodian.
As many as 1,235 fresh foreign portfolio investors (FPIs) were registered with Sebi in April-December of the current fiscal, latest Sebi data showed.
India's decision to relax FDI norms in various sectors would make it a much more attractive destination for overseas investors, USISPF said.
In talks to sell MF and broking units for Rs 600 Cr
Bain Capital , Warburg, Yes Bank and IndusInd said to have expressed interest
The AMC business had an AUM of Rs 66392 cr and PAT of Rs 58 cr in FY17
The Securities business had a PAT of Rs 29 cr in FY17
Economic Times Reports
Taj Mansingh auction to begin on 19th June18 as per NDMC notice
NDMC - New Delhi Municipality Council
Potential bidders can submit bids starting from 18th May
The hotel is a 292 room five star hotel currently operated by IHCL
Zydus Gets final approval from USFDA for Methylprednisolone
Will be manufactured at formulations manufacturing facility at Moraiya, Ahmedabad
Also received final approval to market Cinacalcet Hydrochloride Tablets
Will be manufactured at facility at SEZ, Ahmedabad